Which peptides have been studied in metabolic research?
-
AOD-9604hGH Fragment 176-191
Growth hormone fragment studied for weight management. Not licensed in the UK; its largest human trial showed no significant weight-loss benefit.
ModerateNot licensed in the UK -
KisspeptinMetastin
Natural reproductive hormone studied in UK trials for low sexual desire and IVF egg maturation. No UK marketing authorisation identified.
LimitedNot licensed in the UK -
MOTS-cMitochondrial open reading…
16-amino-acid peptide encoded in mitochondrial DNA, studied in mice and cells. Not licensed in the UK. No published trial gave MOTS-c to people; human studies measured the body's own levels.
PreliminaryNot licensed in the UK -
TesamorelinTH9507
Not licensed in the UK. Growth-hormone-releasing hormone analogue studied for visceral fat in HIV-associated lipodystrophy, in randomised trials.
StrongNot licensed in the UK
Best recorded finding for each peptide in this area
| Peptide | UK status | Finding | Study type | Evidence grade |
|---|---|---|---|---|
| AOD-9604 | Not licensed in the UK | Six pooled Phase I/II trials | Human trial | Moderate |
| Cagrilintide | Not licensed in the UK | Brain amylin receptor mechanism | Animal | Preliminary |
| Kisspeptin | Not licensed in the UK | No effect on food intake | Human trial | Limited |
| Liraglutide | Licensed UK medicine | SCALE prediabetes progression trial | Human trial | Moderate |
| Mazdutide | Not licensed in the UK | Phase 3 in type 2 diabetes | Human trial | Moderate |
| MOTS-c | Not licensed in the UK | Discovery paper, mice and cells | Animal | Preliminary |
| Retatrutide | Not licensed in the UK | Liver fat in MASLD | Human trial | Limited |
| Semaglutide | Licensed UK medicine | The SELECT cardiovascular trial | Human trial | Strong |
| Survodutide | Not licensed in the UK | Liver fat in obesity with MASLD | Human trial | Moderate |
| Tesamorelin | Not licensed in the UK | HIV visceral fat trial | Human trial | Strong |
| Tirzepatide | Licensed UK medicine | Obstructive sleep apnoea trial | Human trial | Strong |
About this research area
"Metabolic Research" groups peptides investigated for effects on glucose regulation, insulin sensitivity, lipid metabolism, visceral fat and related body-composition markers. It is distinct from the broader Weight Management category in that the underlying research question is metabolic function rather than body-weight outcome specifically, though the two frequently overlap in practice. Evidence spans in-vitro and animal-preclinical mechanistic work through to human randomised controlled trials, and includes at least one case where a controlled human trial testing a metabolic endpoint reported no significant effect. Classification in this area denotes a studied metabolic research question, not a confirmed metabolic benefit.
32 sources in the library relate to this area. See them.
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.